Liu X, Li Y, Huang L, Kuang Y, Wu X, Ma X
Front Pharmacol. 2024; 15:1450704.
PMID: 39139642
PMC: 11319138.
DOI: 10.3389/fphar.2024.1450704.
Al-Aqtash R, Collier D
Channels (Austin). 2024; 18(1):2355150.
PMID: 38762911
PMC: 11110710.
DOI: 10.1080/19336950.2024.2355150.
Yin Y, Wei L, Caseley E, Lopez-Charcas O, Wei Y, Li D
Med Res Rev. 2023; 43(5):1346-1373.
PMID: 36924449
PMC: 10947395.
DOI: 10.1002/med.21952.
Maali A, Gholizadeh M, Feghhi-Najafabadi S, Noei A, Seyed-Motahari S, Mansoori S
Front Immunol. 2023; 14:1012841.
PMID: 36761751
PMC: 9905824.
DOI: 10.3389/fimmu.2023.1012841.
Meegan J, Komalavilas P, Cheung-Flynn J, Yim T, Putz N, Jesse J
Physiol Rep. 2022; 10(11):e15290.
PMID: 35668576
PMC: 9170948.
DOI: 10.14814/phy2.15290.
Direct synthesis of 2-oxo-acetamidines from methyl ketones, aromatic amines and DMF copper-catalyzed C(sp)-H amidination.
Xie D, He W, Xiao J, Wu Y, Guo Y, Liu Q
RSC Adv. 2022; 9(13):7203-7209.
PMID: 35519951
PMC: 9061129.
DOI: 10.1039/c9ra00616h.
P2X4 and P2X7 are essential players in basal T cell activity and Ca signaling milliseconds after T cell activation.
Brock V, Wolf I, Er-Lukowiak M, Lory N, Stahler T, Woelk L
Sci Adv. 2022; 8(5):eabl9770.
PMID: 35119925
PMC: 8816335.
DOI: 10.1126/sciadv.abl9770.
Structural basis for the functional properties of the P2X7 receptor for extracellular ATP.
Jiang L, Caseley E, Muench S, Roger S
Purinergic Signal. 2021; 17(3):331-344.
PMID: 33987781
PMC: 8410900.
DOI: 10.1007/s11302-021-09790-x.
Association of P2X7 receptor genetic polymorphisms and expression with rheumatoid arthritis susceptibility in a sample of the Iranian population: a case-control study.
Bahari G, Tabasi F, Hashemi M, Zakeri Z, Taheri M
Clin Rheumatol. 2021; 40(8):3115-3126.
PMID: 33580375
DOI: 10.1007/s10067-021-05645-3.
P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis.
Ruiz-Ruiz C, Calzaferri F, Garcia A
Front Mol Neurosci. 2020; 13:93.
PMID: 32595451
PMC: 7303288.
DOI: 10.3389/fnmol.2020.00093.
Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
Al-Khalidi R, Panicucci C, Cox P, Chira N, Rog J, Young C
Acta Neuropathol Commun. 2018; 6(1):27.
PMID: 29642926
PMC: 5896059.
DOI: 10.1186/s40478-018-0530-4.
Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway.
Fan J, Zhao R, Parro C, Zhao W, Chou H, Robert J
J Lipid Res. 2018; 59(5):830-842.
PMID: 29563219
PMC: 5928439.
DOI: 10.1194/jlr.M081851.
The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?.
Savio L, De Andrade Mello P, da Silva C, Coutinho-Silva R
Front Pharmacol. 2018; 9:52.
PMID: 29467654
PMC: 5808178.
DOI: 10.3389/fphar.2018.00052.
Mild Reductive Functionalization of Amides into -Sulfonylformamidines.
Trillo P, Slagbrand T, Tinnis F, Adolfsson H
ChemistryOpen. 2017; 6(4):484-487.
PMID: 28794940
PMC: 5542752.
DOI: 10.1002/open.201700087.
Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
Allsopp R, Dayl S, Schmid R, Evans R
Sci Rep. 2017; 7(1):725.
PMID: 28389651
PMC: 5429621.
DOI: 10.1038/s41598-017-00732-5.
Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.
Willekens S, Van Weehaeghe D, Van Damme P, Van Laere K
Eur J Nucl Med Mol Imaging. 2016; 44(3):533-547.
PMID: 27933416
DOI: 10.1007/s00259-016-3587-y.
Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists.
Caseley E, Muench S, Fishwick C, Jiang L
Biochem Pharmacol. 2016; 116:130-9.
PMID: 27481062
PMC: 5012888.
DOI: 10.1016/j.bcp.2016.07.020.
Synthesis, SAR, and Pharmacological Characterization of Brain Penetrant P2X7 Receptor Antagonists.
Savall B, Wu D, De Angelis M, Carruthers N, Ao H, Wang Q
ACS Med Chem Lett. 2015; 6(6):671-6.
PMID: 26101572
PMC: 4468405.
DOI: 10.1021/acsmedchemlett.5b00089.
Adamantyl analogues of paracetamol as potent analgesic drugs via inhibition of TRPA1.
Fresno N, Perez-Fernandez R, Goicoechea C, Alkorta I, Fernandez-Carvajal A, de la Torre-Martinez R
PLoS One. 2014; 9(12):e113841.
PMID: 25438056
PMC: 4249970.
DOI: 10.1371/journal.pone.0113841.
Flow Synthesis and Biological Studies of an Analgesic Adamantane Derivative That Inhibits P2X7-Evoked Glutamate Release.
Battilocchio C, Guetzoyan L, Cervetto C, Di Cesare Mannelli L, Frattaroli D, Baxendale I
ACS Med Chem Lett. 2014; 4(8):704-9.
PMID: 24900736
PMC: 4027228.
DOI: 10.1021/ml400079h.
